Delayed Endolymphatic Hydrops (DEH) is a unique inner ear disorder characterized by the emergence of Meniere's-like symptoms many years after a significant hearing loss in the contralateral ear. Unlike typical Meniere's disease which often affects one ear primarily and progresses, DEH specifically refers to the `delayed` onset of classic Meniere's symptoms in the ear previously unaffected by the initial profound hearing impairment.

The core pathology underlying DEH, similar to Meniere's disease, is `endolymphatic hydrops`. This condition involves an abnormal accumulation and distension of endolymph within the membranous labyrinth of the inner ear. In DEH, this hydrops develops after a significant latency period, often decades, following a unilateral profound sensorineural hearing loss, typically from causes such as mumps, trauma, or sudden idiopathic hearing loss in the other ear.

Patients with DEH experience episodes of fluctuating hearing loss, tinnitus, and vertigo or dizziness, mirroring the symptomatology of `Meniere's` disease. However, the critical differentiating factor is the history of the previous, severe hearing loss in the opposite ear and the `delayed` appearance of these episodic symptoms. The mechanisms by which prior severe hearing loss in one ear predisposes the contralateral ear to `endolymphatic hydrops` years later are not fully understood, but theories often involve altered fluid dynamics or autoimmune responses.

Diagnosis of DEH relies on a careful clinical history, audiological testing, and sometimes inner ear imaging techniques. Audiological findings typically show fluctuating sensorineural hearing loss in the affected ear, contrasting with the profound stable loss in the contralateral ear. Management strategies for DEH are similar to those for Meniere's disease, focusing on symptom control. This may include dietary modifications (e.g., low-salt diet), diuretics, vestibular suppressants during acute attacks, and sometimes transtympanic injections or surgical interventions in severe, intractable cases. Understanding the `delayed` nature of this form of `endolymphatic hydrops` is crucial for proper diagnosis and tailored treatment.